Envista (NVST) Competitors $20.90 -0.55 (-2.54%) Closing price 03:59 PM EasternExtended Trading$20.88 -0.03 (-0.14%) As of 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends NVST vs. SOLV, SNN, PEN, GKOS, STVN, BLCO, INSP, NARI, PRCT, and IRTCShould you be buying Envista stock or one of its competitors? The main competitors of Envista include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), PROCEPT BioRobotics (PRCT), and iRhythm Technologies (IRTC). These companies are all part of the "medical equipment" industry. Envista vs. Solventum Smith & Nephew Penumbra Glaukos Stevanato Group Bausch + Lomb Inspire Medical Systems Inari Medical PROCEPT BioRobotics iRhythm Technologies Solventum (NYSE:SOLV) and Envista (NYSE:NVST) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, community ranking, institutional ownership, earnings, analyst recommendations, valuation and dividends. Which has stronger earnings and valuation, SOLV or NVST? Solventum has higher earnings, but lower revenue than Envista. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventumN/AN/AN/AN/AN/AEnvista$2.51B1.43-$1.12B-$6.49-3.22 Does the media favor SOLV or NVST? In the previous week, Solventum had 5 more articles in the media than Envista. MarketBeat recorded 9 mentions for Solventum and 4 mentions for Envista. Envista's average media sentiment score of 1.11 beat Solventum's score of 0.95 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 6 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in SOLV or NVST? Envista received 33 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 35.79% of users gave Envista an outperform vote while only 5.56% of users gave Solventum an outperform vote. CompanyUnderperformOutperformSolventumOutperform Votes15.56%Underperform Votes1794.44% EnvistaOutperform Votes3435.79% Underperform Votes6164.21% Is SOLV or NVST more profitable? Solventum has a net margin of 0.00% compared to Envista's net margin of -44.56%. Envista's return on equity of 3.86% beat Solventum's return on equity.Company Net Margins Return on Equity Return on Assets SolventumN/A N/A N/A Envista -44.56%3.86%2.21% Do analysts prefer SOLV or NVST? Solventum currently has a consensus price target of $68.29, indicating a potential downside of 6.56%. Envista has a consensus price target of $20.21, indicating a potential downside of 3.33%. Given Envista's stronger consensus rating and higher probable upside, analysts plainly believe Envista is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Envista 2 Sell rating(s) 9 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.07 SummaryEnvista beats Solventum on 9 of the 11 factors compared between the two stocks. Get Envista News Delivered to You Automatically Sign up to receive the latest news and ratings for NVST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVST vs. The Competition Export to ExcelMetricEnvistaDental equipment & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$3.60B$3.88B$5.80B$20.04BDividend YieldN/A1.79%4.78%3.65%P/E Ratio-3.2236.7526.4134.90Price / Sales1.431.63450.1415.61Price / Cash13.106.6544.0420.85Price / Book1.230.837.634.92Net Income-$1.12B-$146.24M$3.18B$1.02B7 Day Performance-3.15%1.85%-1.82%-1.05%1 Month Performance1.84%1.91%0.22%-1.40%1 Year Performance-6.55%212.78%17.25%13.93% Envista Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVSTEnvista3.5382 of 5 stars$20.91-2.5%$20.21-3.3%-6.5%$3.60B$2.51B-3.2212,300SOLVSolventum0.399 of 5 stars$74.04-0.4%$68.29-7.8%N/A$12.79BN/A0.0022,000Upcoming EarningsSNNSmith & Nephew2.483 of 5 stars$25.72+0.0%N/A-9.8%$11.24B$5.55B0.0018,452Upcoming EarningsPENPenumbra4.459 of 5 stars$267.83-1.9%$261.36-2.4%+12.7%$10.28B$1.06B311.434,200Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGKOSGlaukos4.399 of 5 stars$153.06+4.6%$151.08-1.3%+71.4%$8.44B$314.71M-50.68780Earnings ReportAnalyst UpgradeInsider TradeNews CoverageGap DownSTVNStevanato Group1.236 of 5 stars€19.49+2.2%N/A-32.5%$5.90B$1.17B41.475,635Positive NewsBLCOBausch + Lomb3.7366 of 5 stars$16.44-1.2%$20.25+23.2%+9.1%$5.79B$4.15B-15.6513,300Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageINSPInspire Medical Systems4.8316 of 5 stars$184.73-1.3%$228.82+23.9%-7.0%$5.54B$624.80M172.651,011Insider TradeNARIInari Medical1.6759 of 5 stars$79.93flat$68.00-14.9%+37.6%$4.68B$493.63M-59.211,300PRCTPROCEPT BioRobotics3.2681 of 5 stars$67.61-2.4%$97.86+44.7%+33.5%$3.53B$199.84M-34.67430Positive NewsIRTCiRhythm Technologies1.0045 of 5 stars$112.11-0.1%$108.45-3.3%+0.2%$3.51B$492.68M-23.072,000Earnings ReportAnalyst ForecastNews CoverageGap Up Related Companies and Tools Related Companies Solventum Alternatives Smith & Nephew Alternatives Penumbra Alternatives Glaukos Alternatives Stevanato Group Alternatives Bausch + Lomb Alternatives Inspire Medical Systems Alternatives Inari Medical Alternatives PROCEPT BioRobotics Alternatives iRhythm Technologies Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:NVST) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envista Holdings Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envista With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
